Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Summary

RATIONALE: Vaccines made from dendritic cells may help the body build an effective immune response to kill cancer cells. PURPOSE: This phase I trial is studying the side effects of vaccine therapy and to see how well it works in treating patients with acute myeloid leukemia in complete remission.

Timeline

Start

2008-06

Primary completion

2011-05

Completion

—

Drugs

Indications